会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明公开
    • NONINVASIVE DETERMINATION OF CARDIAC OUTPUT, PULMONARY BLOOD FLOW, AND BLOOD GAS CONTENT
    • 心脏的非侵入性测定,肺血流量和血液气体含量
    • EP1257201A1
    • 2002-11-20
    • EP00959742.8
    • 2000-09-01
    • NTC Technology Inc.
    • ORR, Joseph, A.KUCK, Kai
    • A61B5/083
    • A61B5/0836A61B5/029G01N33/497G01N2001/2244
    • A method of noninvasively determining the pulmonary capillary blood flow or cardiac output of a patient, including the use of rebreathing techniques to measure the respiratory flow and carbon dioxide pressure of the patient's breathing. These measurements are used to calculate carbon dioxide elimination and an indicator of the carbon dioxide content of the patient's blood, such as the end tidal pressure of carbon dioxide (PetCO2), CaCO2, or pCO2. The location and orientation of a best-fit line through the carbon dioxide elimination data and the data of the indicator of carbon dioxide content is determined by linear regression or by plotting the carbon dioxide elimination data against the data of the indicator of carbon dioxide content. At least one set of the data is modified and at least one other determination of the best-fit line made to find a data set that correlates most closely to the best fit line. The data may be modified by filtering or clustering. The slope of the best-fit line that correlates most closely to the data is then used to determine the pulmonary capillary blood flow or cardiac output of the patient. When the indicator of carbon dioxide content is CaCO2, the negative of the slope of the best fit line is equal to the pulmonary capillary blood flow of the patient.